The AJC in 1987

The AJC in 1987

FROM THE EDITOR The AJC in 1987 The year 1987 was a good one for the AJC. A total of 2,833 pages for articles (2,810 pages) and letters (23 pages) w...

427KB Sizes 5 Downloads 113 Views

FROM THE EDITOR

The AJC in 1987

The year 1987 was a good one for the AJC. A total of 2,833 pages for articles (2,810 pages) and letters (23 pages) was published in the 16 regular issues of the AJC in 1987 (Table I). This number represents an increase of 189 pages (7%)‘for articles and letters compared to 1986. In addition to these 2,833 pages, 395 other editorial (i.e., nonadvertising) pages were published in the regular issues in 1987. Of this number, 202 were used for the “contents with abstracts,” and I am pleased to report that the publisher is considering discontinuing this section in July 1988. The publisher also will change the layout of the “contents in brief” in July 1988. The number of articles published in the regular issues in 1987 was 695, an average of 58 each month, and an increase of 79 articles (11%) compared to 1986 (Table I). Each of the 695 articles averaged 4.04 pages in length, a 5 % decrease in average article length compared to the preceding year. Although the percent of articles in each of the various categories in 1987 was roughly similar to what it had been in 1986, the number of articles on systemic hypertension increased to 28

TABLE

I

Number For For For For For For For For

Number

of Pages

and Types

of pages (mean/month) articles (pages/article) letters (number) [no. with replies] staff, editorial board contents in brief contents with abstracts volume indexes information for authors other

Number of articles (mean/month) Coronary artery disease Arrhythmias and conduction Systemic hypertension Congestive heart failure Valvular heart disease Cardiomyopathy Congenital heart disease Miscellaneous Methods Experimental studies Editorials Brief reports Historical studies AJC 25 years ago From-the-editor columns

defects

of Articles

Published

from 10 in the preceding year (Table I). Because systemic hypertension is such a common condition (60 million Americans have it), articles on this subject should, in my view, occupy more than 4% of the articles published. No experimental articles were published in 1987 (except those which could fit into the Brief Report format). I am enormously pleased about how the Brief Reports section of the AJC has developed during the past 5.5 years. This section was initiated in September 1982. In 1983, 65 (80 % ) of the 81 brief reports published were single-case studies (Table II); in 1984, 122 (60 %) of the 204 brief reports published were single-case studies; in 1985, 54% were single-case studies and in 1987 only 34 % of the 203 brief reports published were single-case studies. In 1987, 33 % of the brief reports involved > IO patients and many involved > 100 patients. It is clear that the Brief Reports section of the Journal is no longer a casereport section. To emphasize this change, beginning in April 1988 the reports which include case descriptions will be placed in a new section to be called simply Case Reporfs. The Brief

in the Regular

Issues

of the AJC in 1983 to 1988

1983

1984

1985

3,435 (286) 3,130 (4.87) 27 (53) [40] 15 28 142 79 12 2

3,403 (284) 3,077 (4.12) 36 (80) [38] 15 31 145 69 15 15

3,014 (251) 2,623 (4.07) 21 (40) 1161 17 44 207 70 17 15

643 (54) 132 (21%) 74 (12%) 18 (3%) 22 (3%) 47 (7%) 22 (3%) 79 (12%) 44 (7%) 29 (5%) 52 (8%) 19 (3%) 81 (13%) 2(<1%) 8(1%) 14 (2%)

747 (62) 140 (19%) 76 (10%) 19 (3%) 16 (2%) 37 (5%) 18 (2%) 47 (6%) 41 (5%) 31(4%) 64 (9%) 28 (4%) 204 (27%) 0 11 (2%) 15 (2%)

672

645 (54) 138(21%) 71(11%) 15 (2%) 18 (3%) 29 (5%) 9 (1%) 38 (6%) 41(7%) 21 (3%) 49 (8%) 16 (3%) 172 (27%) 3 (1%) 13 (2%) 12 (2%)

1986 3,004 2,627

1987

(4.26)

17 (40) 16 44 179 86 15 20 616 (51) 153 (25%) 86 (14%) 10 (2%) 21 (3%) 39 (6%) 7 (1%) 34 (6%) 44 (7%) 9 (1%) 4(1%) 21(3%) 160 (26%) 5(1%) 11(2%) 12 (2%)

[sl

3,228 2,810 (4.04) 23 (45) [ 181 16 50 202 101 16 IO 695 (58) 180 (27%) 83 (12%) 28 (4%) 25 (3%) 30 (4%) 14 (2%) 31(4%) 26 (4%) 24 (3%) 0 26 (4%) 203 (29%) 7(1%) S(l%) 12 (2%)

March

TABLE

II

Brief Reports

Ill

Subjects

Number A

January

23

B C D

January 30 March 9 April 24

E

April

F

May 15

G H J A

May 29 June 15 June 30 July 15

B

July 31

C

August

30

of Brief Reports

204 (17) (27%) 308 (26) (10%)

172 (14) (27%) 278 (23) (11%)

160 (13) (26%) 276 (23) (11%)

203 367

1(1%) 65 (80%) 9{11%) 5 (6%) 0 0 l(l%) 0 0 0 183 (1.49) 22 (0.18)

0 122 (60%) 33 (16%) 12 (6%) 8 (4%) 5 (2%) 4(2%) 9 (4%) 3 (1.5%) 7 (3%) 432 (1.40) 56 (0.27)

7 93 18 5 3 6 12 13 6 9 302 57

1 (
7 (:3 % ) 68 (34%) 18 (9%) 10 (!5 % ) 9 (4%) 3 (:2 % ) 21(10%) 23(11%) 15 (8%) 29 (14%) 336 (1.66) 142 (0.70)

Published

in the American

Title Calcium Ion, Cardiac Myocyte, Vascular Smooth Muscle in Hypertension Calcium Antagonists Total lschemic Burden Ramipril-A New Angiotensin Converting Enzyme Inhibitor Proarrhythmia

Enoximone for Heart Failure

(4%) (54%) (10%) (3%) (2%) (3%) (7%) (8%) (4%) (5%) (1.76) (0.33)

1987 (17) (29%) (31) (13%)

in the AJC 1983 to 1987

Betablockade, Cardioselectivity and Intrinsic Sympathomimetic Activity Doxazosin Pirmenol Nicardipine Cardioprotection in lschemic Heart Disease Restenosis After PTCA 14

673

61

81 (7) (13%) 123 (10) (4%)

1984

81

Day

Volume

1986

Totals

Month,

OF CARDIOLOGY

1985

19 (23%) 15 (19%) 0 0 7 (9%) 7 (9%) 19 (23%) 13 (16%) 0 l(l%) 0

Symposia

JOURNAL

1984

Coronary artery disease Arrhythmias and conduction Systemic hypertension Congestive heart failure Valvular heart disease Cardiomyopathy Miscellaneous topics Congenital heart disease Methods Experimental studies Historical studies

IV

AMERICAN

1983

1983

TABLE

THE

in the AJC 1983 to 1987

No. of reports (no/month) (% of total) No. of pages (no./month) (% of total) No. of patients in each report 0 1 2 3 4 5 6-10 1 l-25 26-50 >50 No. of figures (no./report) No. of tables (no./report)

TABLE

1, 1988

1985

Guest

of Cardiology

26 (15%) 0 2(1%) 17 (10%) 11 (6%) 37 (22%) 34 (20%) 4(2%) 2(1%) 0 172

57 (28 %) 34 (17%) 2(1%) ,4 (2%) 33 (16%) f8 (4%) 28 (14%) 29 (14%) 2(1%) 16 (3%) 0

160

203

in 1987

Pages

19

121

Marion

Eugene Braunwald Attilio Maseri J. Ian S. Robertson

25 7 31

187 38 177

Sandoz Pharmaceuticals Pfizer Laboratories Hoechst AG

Sept. 11-12, 1986 September 14, 1986 May 2-4, 1986

4 5 11

Leonard N. Horowitz Douglas P. Zipes Aram V. Chobanian Stanley H. Taylor

10

56

Berlex

Laboratories

March

14

12

54

Wyeth

Laboratories

Sept.

Klaus Starke H. Just William W. Parmley Desmond Julian

18 12 8 8

104 57 37 41

Pfizer International Warner-Lambert Syntex International ICI Pharmaceuticals

June 7, 1986 December 2, 1985 September 13, 1986 January 18, 1986

11 19 9 18

16

69

June

14

18

90

USCI, Division of G.R. Bard Merrell Dow Research Institute

Spencer

D. Frohlich

B. King,

Karl T. Weber

Ill

Sponsor Laboratories

Date March

of Symposium

Interval (months) Symposium to Publication

Articles

Edward

Editor(s)

1987

25 (16%) 39 (24%) 2(1%) 3 (2%) 22 (14%) 7 (4%) 29 (18%) 27 (17%) 0 3 (2%) 3 (2%)

39 (23%)

33 (16%) 45 (22%) 1 (
Journal

1986

27-29,

1986

9, 1986 28-29,

1986

7, 1986

September

14, 1986

10

8

11

674 TABLE

Number

IV

Symposia

Month,

Day

Published

in the American

Title

D

August

31

E

September

F G

October October

H I

November December

16 14

J

December

28

16 16 30

Beta blockers as AntiArrhythmic Agents Beta Blocker with ISA for Hypertension Moricizine HCI New Approaches to Cardiovascular Therapy Nitroglycerin Hypertension-The Heart and Kidney Behavioral Disorders in Heart Disease

Journal

Guest Joel

of Cardiology in 1987 (cont’d.)

Editor(s)

Morganroth

Articles

Pages

12

67

Sponsor

William

C. Roberts

7

37

Princeton Pharmaceutical Products (Squibb) RhBne-Poulenc Sante

Bernard George

Lown L. Blackburn

14 15

89 93

DuPont Sandoz

Jonathan Edward

Abrams D. Frolich

10 24

48 132

13

79

Sheldon H. Gottlieb Rudolf Hoehn-Saric

Reports will be reserved for major studies that are concise and have only 1 or 2 major points. At least a third of the articles published as Brief Reports were initially submitted as regular length articles but converted to the shorter format. I urge the readership to examine the brief reports more carefully because these reports provide the most information per page of any section in the Journal. The topics of the Brief Reports in 1987 were roughly similar to what they had been in 1986 (Table Ill). The editor particularly welcomes reader reaction to the Brief Reports. And 1987 also was a good year for supplements. A total of 19 supplements was published in the AJC, and they included 279 articles occupying 1,576 pages (Table IV). Some of the more prominent cardiovascular investigators in the world served as guest editors of these supplements. The average interval between the symposium meeting and the publication of the proceedings of the symposium was 12 months. Supple-

Date

of Symposium

December

12-13,1986

April 20, 1985 March 5-6,1987

28 8

W. H. Rorer Marion Laboratories

September April 9-11,

14 8

Upjohn

April

3-4,

1986

8

June

Pharmaceuticals

23-27,

Interval (months) Symposium to Publication

13, 1966 1987 1987

15

9

ments are published, however, within 3 months of receipt of all the manuscripts by the editor. Thus, including both regular issues and supplements a total of 974 articles occupying 4,412 pages was published in the AJC in 1987. At a yearly subscription cost of $66.00, each article in 1987 cost a subscriber <7 pennies and each page for articles and letters, <2 pennies. The subscription cost throughout 1988 will remain the same as in 1987, so the Journal in 1988 should be an even better bargain.

William C. Roberts, Editor-in-Chief

MD